Glenmark Life Sciences informs about offer letter

09 Feb 2024 Evaluate
Glenmark Life Sciences has informed that DAM Capital Advisors (Manager to the Offer) has submitted a copy of Letter of Offer to the Public Shareholders of Glenmark Life Sciences (Target Company).

The above information is a part of company’s filings submitted to BSE.

Alivus Life Sciences Share Price

892.05 12.65 (1.44%)
10-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.25
Dr. Reddys Lab 1251.10
Cipla 1489.15
Zydus Lifesciences 923.70
Lupin 2055.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×